Paracervical Injection for Headache in the Emergency Department
Status:
Recruiting
Trial end date:
2022-09-15
Target enrollment:
Participant gender:
Summary
Headache is one of the most common presenting complaints in the emergency department.1 By the
time patients with benign headaches present for treatment in the ED, they often have
exhausted non-invasive treatments, and physicians are left with few therapeutic options. The
investigators therefore propose to study the use of paracervical injection as a novel
approach to managing headache in the emergency department. This procedure has great
potential, if efficacious, to provide a safe, rapidly effective, non-sedating treatment for
headache that does not involve intravenous line placement and systemic medication
administration. To date, there are no published trials that evaluate this technique in this
setting. The investigators intend to compare the efficacy of paracervical injection to
standard first-line therapy (intravenous prochlorperazine and diphenhydramine) for the
treatment of benign headache of any etiology in the emergency department.